Quarterly report pursuant to Section 13 or 15(d)

Condensed Interim Consolidated Statements of Cash Flows

v3.7.0.1
Condensed Interim Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2017
Mar. 31, 2016
Cash Flows Used In Operating Activities:        
Net loss $ (1,103,677) $ (861,010) $ (2,589,349) $ (2,490,813)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization     90,720 68,732
Share-based compensation     64,794 167,329
Foreign exchange (gain) loss (35,227) (226,764) 42,163 (117,636)
Loss in fair value of warrant liability 0 0 0 211,956
Changes in working capital items:        
Accounts receivable     19,899 147,209
Inventory     (61,144) 13,817
Prepaid expenses     (18,053) (34,907)
Deposits     0 560
Accounts payable and accrued liabilities     (190,227) (213,773)
Net cash used in operating activities     (2,641,197) (2,247,526)
Cash Flows From Investing Activities:        
Acquisition of property, plant and equipment     (126,876) (263,242)
Purchase of short-term investments     (2,005,570) (2,005,818)
Proceeds on sales and maturities of short-term investments     2,000,000 5,021,827
Net cash provided by (used in) investing activities     (132,446) 2,752,767
Cash Flows From Financing Activities:        
Proceeds from exercise of warrants and options     0 1,368,260
Net cash provided by financing activities     0 1,368,260
Effect of exchange rate changes on cash and cash equivalents     (42,039) 132,723
Net change in cash and cash equivalents     (2,815,682) 2,006,224
Cash and cash equivalents - beginning of period     7,416,904 3,955,503
Cash and cash equivalents - end of period 4,601,222 5,961,727 4,601,222 5,961,727
Cash (demand deposits) 850,224 5,961,727 850,224 5,961,727
Cash equivalents 3,750,998 0 3,750,998 0
Cash and cash equivalents $ 4,601,222 $ 5,961,727 $ 4,601,222 $ 5,961,727